Novonesis (Novozymes) B (NSISBC.XD)

DKK 410.0

(-0.89%)

Long Term Debt Summary of Novonesis (Novozymes) B

  • Novonesis (Novozymes) B's latest annual long term debt in 2023 was 4.32 Billion DKK , up 10.8% from previous year.
  • Novonesis (Novozymes) B's latest quarterly long term debt in 2024 Q2 was 7.99 Billion DKK , down -0.01% from previous quarter.
  • Novonesis (Novozymes) B reported annual long term debt of 3.9 Billion DKK in 2022, down -3.29% from previous year.
  • Novonesis (Novozymes) B reported annual long term debt of 4.04 Billion DKK in 2021, up 11.29% from previous year.
  • Novonesis (Novozymes) B reported quarterly long term debt of 7.99 Billion DKK for 2024 Q2, down -0.01% from previous quarter.
  • Novonesis (Novozymes) B reported quarterly long term debt of 4.56 Billion DKK for 2023 FY, up 16.74% from previous quarter.

Annual Long Term Debt Chart of Novonesis (Novozymes) B (2023 - 2019)

Historical Annual Long Term Debt of Novonesis (Novozymes) B (2023 - 2019)

Year Long Term Debt Long Term Debt Growth
2023 4.32 Billion DKK 10.8%
2022 3.9 Billion DKK -3.29%
2021 4.04 Billion DKK 11.29%
2020 3.63 Billion DKK 14.91%
2019 3.15 Billion DKK 0.0%

Peer Long Term Debt Comparison of Novonesis (Novozymes) B

Name Long Term Debt Long Term Debt Difference